Reports on U.S. Centers for Medicare and Medicaid Services' proposed rules on drug reimbursement. Impact of the proposed rules on the biotechnology industry; Scenarios that CMMS could use to pay for drugs administered in a physician's office; Proposed changes in the reimbursement of drugs in the outpatient setting.